![Max Petersson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Max Petersson
Directeur des opérations chez Accuro Immunology AB
Postes actifs de Max Petersson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Directeur des opérations | - | - |
Historique de carrière de Max Petersson
Anciens postes connus de Max Petersson
Sociétés | Poste | Début | Fin |
---|---|---|---|
AngioGenetics AB
![]() AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Corporate Officer/Principal | - | - |
Formation de Max Petersson
Karolinska Institutet | Doctorate Degree |
Statistiques
Internationale
Suède | 4 |
Opérationnelle
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Accuro Immunology AB
![]() Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
AngioGenetics AB
![]() AngioGenetics AB Pharmaceuticals: GenericHealth Technology AngioGenetics AB develops, markets, and distributes generic drugs. It develops angiogenesis modulating drugs for the treatment of cancer, ischemic heart disease, and eye diseases. The company was founded in June 2001 and is headquartered in Göteborg, Sweden. | Health Technology |
- Bourse
- Insiders
- Max Petersson
- Expérience